___

• 1. Fokdal L, Sturdza A, Mazeron R, Haie-Meder C, Tan LT, Gillham C, et al. Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study. Radiother Oncol 2016;120(3):434–40.
• 2. Nomden CN, de Leeuw AA, Moerland MA, Roesink JM, Tersteeg RJ, Jurgenliemk-Schulz IM. Clinical use of the Utrecht applicator for combined intracavitary/ interstitial brachytherapy treatment in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2012;82(4):1424–30.
• 3. Jurgenliemk-Schulz IM, Tersteeg RJ, Roesink JM, Bijmolt S, Nomden CN, Moerland MA, et al. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer. Radiother Oncol. 2009;93(2):322–30.
• 4. Kirisits C, Lang S, Dimopoulos J, Berger D, Georg D, Potter R. The Vienna applicator for combined intracav itary and interstitial brachytherapy of cervical cancer: Design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys 2006;65(2):624–30.
• 5. Tambas M, Tavli B, Bilici N, Dizman A, Sertel H, Fayda M. Computed tomography-guided optimization of needle insertion for combined intracavitary/ interstitial brachytherapy with utrecht applicator in locally advanced cervical cancer. Pract Radiat Oncol 2021;11(4):272–81.
• 6. Haie-Meder C, Potter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005;74(3):235–45.
• 7. Potter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D imagebased treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006;78(1):67–77.
• 8. Hellebust TP, Kirisits C, Berger D, Perez-Calatayud J, De Brabandere M, De Leeuw A, et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group: Considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol 2010;96(2):153–60.
• 9. Dimopoulos JC, Petrow P, Tanderup K, Petric P, Berger D, Kirisits C, et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol 2012;103(1):113–22.
• 10.Berger T, Seppenwoolde Y, Potter R, Assenholt MS, Lindegaard JC, Nout RA, et al. Importance of technique, target selection, contouring, dose prescription, and dose-planning in external beam radiation therapy for cervical cancer: Evolution of practice from EMBRACE-I to II. Int J Radiat Oncol Biol Phys 2019;104(4):885–94.
• 11.Fokdal L, Tanderup K, Hokland SB, Rohl L, Pedersen EM, Nielsen SK, et al. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component. Radiother Oncol 2013;107(1):63–8.
• 12.Potter R, Georg P, Dimopoulos JC, Grimm M, Berger D, Nesvacil N, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011;100(1):116–23.
• 13.Dimopoulos JC, Kirisits C, Petric P, Georg P, Lang S, Berger D, et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys 2006;66(1):83–90.
• 14.Otter S, Coates A, Franklin A, Cunningham M, Stewart A. Improving dose delivery by adding interstitial catheters to fixed geometry applicators in high-doserate brachytherapy for cervical cancer. Brachytherapy 2018;17(3):580–6.
• 15.Nomden CN, de Leeuw AA, Van Limbergen E, de Brabandere M, Nulens A, Nout RA, et al. Multicentre treatment planning study of MRI-guided brachytherapy for cervical cancer: Comparison between tandem-ovoid applicator users. Radiother Oncol 2013;107(1):82–7.
• 16.Serban M, Kirisits C, de Leeuw A, Potter R, Jurgenliemk-Schulz I, Nesvacil N, et al. Ring versus ovoids and intracavitary versus intracavitary-interstitial applicators in cervical cancer brachytherapy: Results from the EMBRACE I study. Int J Radiat Oncol Biol Phys 2020;106(5):1052–62.
• 17.Tanderup K, Fokdal LU, Sturdza A, Haie-Meder C, Mazeron R, van Limbergen E, et al. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. Radiother Oncol 2016;120(3):441–6.
• 18.Mazeron R, Gouy S, Escande A, Dumas I, Del Campo ER, Bentivegna E, et al. Locally advanced cervical cancer: Is it relevant to report image-guided adaptive brachytherapy using point A dose? Brachytherapy 2017;16(4):862–9.
• 19.Kirchheiner K, Nout RA, Lindegaard JC, HaieMeder C, Mahantshetty U, Segedin B, et al. Doseeffect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study. Radiother Oncol 2016;118(1):160–6.
• 20.Manea E, Escande A, Bockel S, Khettab M, Dumas I, Lazarescu I, et al. Risk of late urinary complications following image guided adaptive brachytherapy for locally advanced cervical cancer: Refining bladder dose-volume parameters. Int J Radiat Oncol Biol Phys 2018;101(2):411–20.
• 21.Spampinato S, Fokdal LU, Potter R, Haie-Meder C, Lindegaard JC, Schmid MP, et al. Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis. Radiother Oncol 2021;158:312–20.